-
1 Comment
Lifespot Health Ltd is currently in a long term uptrend where the price is trading 3.3% above its 200 day moving average.
From a valuation standpoint, the stock is 60.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 101.7.
Lifespot Health Ltd's total revenue rose by 144.3% to $104K since the same quarter in the previous year.
Its net income has increased by 59.5% to $-545K since the same quarter in the previous year.
Finally, its free cash flow grew by 46.1% to $-254K since the same quarter in the previous year.
Based on the above factors, Lifespot Health Ltd gets an overall score of 5/5.
| Exchange | AU |
|---|---|
| CurrencyCode | AUD |
| ISIN | AU0000179475 |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| PE Ratio | None |
|---|---|
| Target Price | None |
| Dividend Yield | 0.0% |
| Beta | -0.5 |
| Market Cap | 16M |
Lifespot Health Ltd provides diagnostic systems and delivery platforms to healthcare enterprises in Australia. The company is developing the BodyTel System that integrates multiple sensors for capturing diagnostic information for additional diseases; Seng-Vital, a Bluetooth enabled vaporizer and health platform designed for the use of medical cannabis; and FeverTel, a dual mode digital thermometer to record and track family's symptoms. Lifespot Health Ltd was incorporated in 2016 and is based in Melbourne, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for LSH.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
